<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Although adipocyte-derived murine resistin links <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> to <z:hpo ids='HP_0001513'>obesity</z:hpo>, the role of human resistin, predominantly expressed in mononuclear cells and induced by inflammatory signals, remains unclear </plain></SENT>
<SENT sid="1" pm="."><plain>Given the mounting evidence that <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory diseases</z:e>, we sought to determine the relationship between inflammatory increases in human resistin and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: To investigate the role of human resistin on <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis in inflammatory states, we generated mice lacking murine resistin but transgenic for a <z:mp ids='MP_0001794'>bacterial</z:mp> artificial chromosome containing human resistin (BAC-Retn), whose expression was similar to that in humans </plain></SENT>
<SENT sid="3" pm="."><plain>The metabolic and molecular phenotypes of BAC-Retn mice were assessed after <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> endotoxemia (i.e., exposure to inflammatory <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi>) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: We found that BAC-Retn mice have circulating resistin levels within the <z:mpath ids='MPATH_458'>normal</z:mpath> human range, and similar to humans, <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> markedly increased serum resistin levels </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> endotoxemia caused <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> in mice lacking murine resistin, and this was attenuated in BAC-Retn mice </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, BAC-Retn mice developed severe hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> under <z:hpo ids='HP_0011010'>chronic</z:hpo> endotoxemia, accompanied by <z:mp ids='MP_0001846'>increased inflammatory responses</z:mp> in liver and skeletal muscle </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These results strongly support the role of human resistin in the development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, human resistin may link <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> to <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory diseases</z:e> such as <z:hpo ids='HP_0001513'>obesity</z:hpo>, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
</text></document>